BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 27936355)

  • 1. Sample size determination for a three-arm equivalence trial of Poisson and negative binomial responses.
    Chang YW; Tsong Y; Zhao Z
    J Biopharm Stat; 2017; 27(2):239-256. PubMed ID: 27936355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sample size determination for a three-arm equivalence trial of normally distributed responses.
    Chang YW; Tsong Y; Dong X; Zhao Z
    J Biopharm Stat; 2014; 24(6):1190-202. PubMed ID: 25098678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sample size for comparing negative binomial rates in noninferiority and equivalence trials with unequal follow-up times.
    Tang Y
    J Biopharm Stat; 2018; 28(3):475-491. PubMed ID: 28541744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sample size calculation for comparing two negative binomial rates.
    Zhu H; Lakkis H
    Stat Med; 2014 Feb; 33(3):376-87. PubMed ID: 24038204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sample size determination for equivalence assessment with multiple endpoints.
    Sun A; Dong X; Tsong Y
    J Biopharm Stat; 2014; 24(6):1203-14. PubMed ID: 25032845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On sample size requirement for analytical similarity assessment.
    Zhao Y; Chang YW; Chow SC
    J Biopharm Stat; 2018; 28(6):1143-1159. PubMed ID: 29513612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sample size determination for assessing equivalence based on proportion ratio under a randomized trial with non-compliance and missing outcomes.
    Lui KJ; Chang KC
    Stat Med; 2008 Jan; 27(1):47-67. PubMed ID: 17708514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling motor vehicle crashes using Poisson-gamma models: examining the effects of low sample mean values and small sample size on the estimation of the fixed dispersion parameter.
    Lord D
    Accid Anal Prev; 2006 Jul; 38(4):751-66. PubMed ID: 16545328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study design for a three-arm equivalence clinical trial with binomially distributed outcomes.
    Tseng YK; Hsu KN
    J Biopharm Stat; 2021 Nov; 31(6):736-744. PubMed ID: 34460350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blinded sample size recalculation in clinical trials incorporating historical data.
    Hees K; Kieser M
    Contemp Clin Trials; 2017 Dec; 63():2-7. PubMed ID: 28735110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional consistency and sample size considerations in a multiregional equivalence trial.
    Wu SC; Xu JF; Zhang XJ; Li ZW; He J
    Pharm Stat; 2020 Nov; 19(6):897-908. PubMed ID: 32716135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and analysis of three-arm trials with negative binomially distributed endpoints.
    Mütze T; Munk A; Friede T
    Stat Med; 2016 Feb; 35(4):505-21. PubMed ID: 26388314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sizing clinical trials when comparing bivariate time-to-event outcomes.
    Sugimoto T; Hamasaki T; Evans SR; Sozu T
    Stat Med; 2017 Apr; 36(9):1363-1382. PubMed ID: 28120524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A noniterative sample size procedure for tests based on t distributions.
    Tang Y
    Stat Med; 2018 Sep; 37(22):3197-3213. PubMed ID: 29876954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A U-statistics based approach to sample size planning of two-arm trials with discrete outcome criterion aiming to establish either superiority or noninferiority.
    Wellek S
    Stat Med; 2017 Feb; 36(5):799-812. PubMed ID: 27878839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A studentized permutation test for three-arm trials in the 'gold standard' design.
    Mütze T; Konietschke F; Munk A; Friede T
    Stat Med; 2017 Mar; 36(6):883-898. PubMed ID: 27859506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Group sequential design and analysis of clinical equivalence assessment for generic nonsystematic drug products.
    Tsong Y; Zhang JJ; Wang SJ
    J Biopharm Stat; 2004 May; 14(2):359-73. PubMed ID: 15206533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selection of the effect size for sample size determination for a continuous response in a superiority clinical trial using a hybrid classical and Bayesian procedure.
    Ciarleglio MM; Arendt CD; Peduzzi PN
    Clin Trials; 2016 Jun; 13(3):275-85. PubMed ID: 26928986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study duration for three-arm non-inferiority survival trials designed for accrual by cohorts.
    Wu Y; Li Y; Hou Y; Li K; Zhou X
    Stat Methods Med Res; 2018 Feb; 27(2):507-520. PubMed ID: 26994213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Equivalence and superiority testing in regeneration clinical trials.
    Gunsolley JC; Elswick RK; Davenport JM
    J Periodontol; 1998 May; 69(5):521-7. PubMed ID: 9623894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.